StepWise USMLE
urogenital · pathology

Penis · Testes · Prostate

High‑yield notes for clinical reasoning & board preparation

🫀 Penis

  • Congenital
    • Epispadias – urethral meatus on dorsal surface
    • Hypospadias – urethral meatus on ventral surface
    • Both ↑ risk UTI & infertility; may associate with undescended testes
  • Acquired inflammatory
    • Balanitis – inflammation of glans; balanoposthitis – glans + foreskin
    • Poor hygiene & lack of circumcision predispose
  • Peyronie disease – penile fibromatosis → curvature during erection
  • HPV‑associated
    • Condyloma acuminatum – cauliflower-like; HPV 6,11
    • Squamous cell carcinoma – HPV 16,18; ↑ risk in uncircumcised
    • Precursor: Bowen disease, bowenoid papulosis, erythroplasia of Queyrat
  • Erectile dysfunction
    • Vascular insufficiency (most common >50 yr)
    • Neurologic: MS, diabetic neuropathy, post‑radical prostatectomy
    • Endocrine: low testosterone, hypothyroidism, prolactinoma
    • Drugs: leuprolide, methyldopa, finasteride, psychotropics
  • Priapism – persistent painful erection
    • Sickle cell anemia (sludging), trauma, trazodone
  • Epispadias/hypospadias often coexist with cryptorchidism – always examine both.

🧬 Testes – nonneoplastic

  • Varicocele – dilated pampiniform plexus; left > right
    • “bag of worms” superior to testis; may cause infertility
  • Hydrocele – fluid in tunica vaginalis
  • Spermatocele – epididymal cyst containing sperm; transilluminates
  • Epididymitis
    • Acute <35 yr: N. gonorrhoeae, C. trachomatis
    • Acute >35 yr: E. coli, Pseudomonas
    • Chronic: TB
  • Orchitis – sudden pain + fever; mumps virus most common
  • Testicular torsion – twisting of spermatic cord; hemorrhagic infarction; surgical emergency
  • Cryptorchidism – failure to descend; inguinal canal most common; ↑ risk seminoma
  • Testicular torsion: painful hemorrhagic infarction → gangrene – do not delay surgical exploration.
  • Male infertility – mechanisms
    • Primary testicular: Leydig cell or seminiferous tubule dysfunction
    • Secondary hypogonadism: pituitary/hypothalamic failure
    • Obstructive: vas deferens obstruction or ejaculatory disorder

⚕️ Testicular cancer

  • Presentation – firm, painless mass; nonseminomas may metastasize widely
  • Risk factors
    • Cryptorchidism (3‑5×)
    • Testicular dysgenesis (Klinefelter, testicular feminization)
    • Family history; Caucasian > African American
  • Diagnostic approach
    • Ultrasound: hypoechoic intratesticular mass
    • Serum markers: AFP, β‑hCG, LDH (tumor burden)
    • Staging: orchiectomy + retroperitoneal lymph node dissection
  • Serum markers – source
    • AFP → yolk sac tumor
    • β‑hCG → choriocarcinoma / syncytiotrophoblasts
    • LDH → nonspecific, reflects tumor bulk
Histologic typeKey featuresPrognosis
Seminomasheets of clear cells, fibrous septa; mean age 40excellent (95% cure early)
Embryonal carcinomaaggressive, bulky, hemorrhage/necrosismore aggressive
Choriocarcinomasmall, hemorrhagic; syncytio‑ + cytotrophoblastshighly malignant, early hematogenous spread
Yolk sac tumorSchiller‑Duval bodies; most common in childrengood in children; variable in adults
Teratomacystic, cartilage/bone; mature vs. immaturebenign in prepubertal; malignant potential in adults
  • Mixed germ cell tumors – ≥2 components (e.g., teratocarcinoma)
  • Sex cord‑stromal
    • Leydig cell: bimodal (prepubertal, >50); may secrete androgens/estrogens → gynecomastia (adults) or precocious puberty (children); 90% benign
    • Sertoli cell: rare, usually benign; tubule formation
  • Other
    • Testicular lymphoma: most common in men >60; diffuse large B‑cell
    • Scrotal SCC: chimney sweeps (soot exposure)
  • Para‑aortic lymph nodes are the first regional metastatic site for testicular cancer.

🧪 Prostate

  • Benign prostatic hyperplasia (BPH)
    • Androgen (DHT)‑driven; not premalignant
    • Incidence: 70% at age 60, 80% at age 70
    • Transition/periurethral zone enlargement → urethral compression
  • BPH – symptoms
    • Decreased stream caliber/force, hesitancy, postvoid dribbling
    • Urgency, frequency, nocturia, dysuria
    • PSA may be mildly elevated (usually <10 ng/mL)
  • BPH – complications UTI, bladder diverticula, hydronephrosis (rare)
  • BPH – treatment
    • TURP (transurethral resection)
    • 5α‑reductase inhibitor: finasteride
    • α‑1 blockers: terazosin, prazosin
DHT→ stromal/glandular hyperplasia→ periurethral nodules→ urethral compression
  • Prostate adenocarcinoma – most common cancer in U.S. men; 2nd cancer death
  • Key features
    • Peripheral zone origin (vs. BPH – transitional)
    • Often asymptomatic; may present with back pain (bone mets)
    • DRE: induration; PSA elevation; transrectal US + biopsy
  • Metastasis – obturator/pelvic lymph nodes; osteoblastic bone (lumbar spine) → ↑ alkaline phosphatase
  • Grading – Gleason score (glandular differentiation); TMPRSS2‑ETS fusion in ~50%
  • Treatment
    • Local: prostatectomy, radiation
    • Metastatic: orchiectomy, estrogens, LHRH agonists, anti‑androgens
  • Prostatitis
    • Acute: intraprostatic reflux of urinary pathogens
    • Chronic: recurrent; nonbacterial chronic pelvic pain syndrome more common
    • Findings: fever, perineal/suprapubic pain, dysuria, hematuria
  • Prostate cancer metastasis to lumbar spine is osteoblastic – elevated ALP, not lytic.
  • BPH involves the transitional zone; prostate cancer arises in the peripheral zone – a key anatomical distinction.